EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -8.066
March 31, 2026 -2.260
December 31, 2025 -2.382
September 30, 2025 -1.638
June 30, 2025 -1.738
March 31, 2025 -1.863
December 31, 2024 -2.328
September 30, 2024 -2.110
June 30, 2024 -2.830
March 31, 2024 -2.852
December 31, 2023 -3.825
September 30, 2023 -1.925
June 30, 2023 -2.455
March 31, 2023 -2.889
December 31, 2022 -2.323
September 30, 2022 -4.404
Date Value
June 30, 2022 -3.715
March 31, 2022 -6.590
December 31, 2021 -5.883
September 30, 2021 -0.219
June 30, 2021 -0.1606
March 31, 2021 -0.14
December 31, 2020 -0.1306
September 30, 2020 -0.1046
June 30, 2020 -0.1016
March 31, 2020 -0.0974
December 31, 2019 -0.1086
September 30, 2019 0.2574
June 30, 2019 -0.2058
March 31, 2019 -0.1174
December 31, 2018 -0.2292
September 30, 2018 -3.013

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 0.5293
Align Technology, Inc. 1.514
AngioDynamics, Inc. -0.1689
Accuray, Inc. -0.0154
Alphatec Holdings, Inc. -0.1647